Create Account | Sign In: Author or Forum

                                              Search Symptoms

                                              Medical Specialty >>


                                              1:03 PM CDT. Read article More News

                                              JOURNAL UPDATE

                                              Home Hazard Removal Program Cuts Rate of Falls Among Elderly

                                              7:46 PM CDT.

                                              While the program did not reduce the hazard of falls, authors say it nonetheless may be an important,…

                                              MONTHLY JOURNAL SUMMARY

                                              September 2020 Briefing - Pharmacy

                                              October 01, 2020. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.

                                              FEATURED ARTICLES

                                              Immunotherapy with Checkpoint Inhibitors in Triple Negative Breast Cancer (TNBC)

                                              Karima Oualla, MD. Dr. Karima Oualla discusses recent advances on the use of checkpoint inhibitors in the treatment of triple negative breast cancer (TNBC). Dr. Oualla is an International expert in breast cancer and is the primary author of the manuscript entitled "Novel therapeutic strategies in the treatment of triple-negative…

                                              Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial

                                              Robert L. Coleman, MD. Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…

                                              Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

                                              Ted Lain, MD. Clinical trial investigator Dr. Ted Lain ments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…

                                              MEDICAL FOCUS

                                              Acute dyspnea (shortness of breath)

                                              By Tamer M. Fouad, M.D.

                                              Dyspnea (shortness of breath) is a term used to characterize a subjective experience of breathing disfort that is prised of qualitatively distinct…


                                              RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

                                              By namabc

                                              As I understand, this is a great step of development that we can use to save many people from horrible diseases. and i also hope Dr.Lain and your partners…


                                              Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website

                                              Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.


                                                                                              小草回家的路2021入口 午夜电影合集10000百度云资源 欧美午夜看片影院 亚洲色精品VR一区区三区 天天爱天天草天天干 七月色色